A Cohort Study to Evaluate the Efficacy and Value of CT Perfusion Imaging in Patients with Metastatic Osteosarcoma after Chemotherapy

• Published in: Computational and mathematical methods in medicine Vol. 2022; pp. 5417753 - 8
• Main Authors: Zhang, Chun qian, Yang, Shuai, Zhang, Li jing, Ma, Jian nan, Chen, De qiang
• Format: Journal Article
• Language: English
• Published: United States Hindawi 19-07-2022
• Subjects: Case-Control Studies; Cohort Studies; Humans; Lung Neoplasms - pathology; Osteosarcoma - diagnostic imaging; Osteosarcoma - drug therapy; Perfusion Imaging - methods; Tomography, X-Ray Computed - methods
• ISSN: 1748-670X; 1748-6718
• DOI: 10.1155/2022/5417753

Objective. A case-control study was conducted to explore the efficacy of cohort study and value of CT perfusion imaging in patients with metastatic osteosarcoma after chemotherapy. Methods. Eighty patients with metastatic osteosarcoma treated in our hospital from March 2020 to December 2021 were divided into two groups. According to their different treatment methods, the chemotherapy+antiangiogenesis group had 36 cases and the chemotherapy group had 44 cases. All patients were scanned by 64-slice spiral CT before and after treatment. The differences of tumor volume and perfusion parameters before and after treatment were compared, and the correlation between perfusion parameters and tumor microvessel density (MVD) was analyzed. The receiver working curve (ROC curve) was used to evaluate the efficacy of the two groups after chemotherapy. Results. Blood flow (BF), blood volume (BV), Pallak blood volume (PBV), and time to start (TTS) in the antitumor angiogenesis+chemotherapy group were significantly lower than those before treatment (P<0.05). Microvessel density was positively correlated with PS, BF, BV, and PBV (P<0.05). The reduction rate of BV and BF in the remission group after treatment was significantly higher than that in the nonremission group. When the BV and BF decline rates were 47.37% and 21.53% and the areas under the curve were 0.968 and 0.916, respectively, the diagnostic effect was the best. When the decrease rate of BV was 47.48% and the decrease rate of BF was 21.55%, the sensitivity was 94.72% and 89.56% and the specificity was 91.31% and 91.31%. Conclusion. The reduction rate of BV and BF in CT perfusion imaging is of high value in evaluating the efficacy of radiotherapy and chemotherapy in patients with NSCLC and can provide more objective basis for observing the changes and judging the prognosis of osteosarcoma after treatment.